BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22892246)

  • 1. Sustained levels of antibodies against Aβ in amyloid-rich regions of the CNS following intravenous dosing in human APP transgenic mice.
    Bard F; Fox M; Friedrich S; Seubert P; Schenk D; Kinney GG; Yednock T
    Exp Neurol; 2012 Nov; 238(1):38-43. PubMed ID: 22892246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A plaque-specific antibody clears existing β-amyloid plaques in Alzheimer's disease mice.
    Demattos RB; Lu J; Tang Y; Racke MM; Delong CA; Tzaferis JA; Hole JT; Forster BM; McDonnell PC; Liu F; Kinley RD; Jordan WH; Hutton ML
    Neuron; 2012 Dec; 76(5):908-20. PubMed ID: 23217740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody capture of soluble Abeta does not reduce cortical Abeta amyloidosis in the PDAPP mouse.
    Seubert P; Barbour R; Khan K; Motter R; Tang P; Kholodenko D; Kling K; Schenk D; Johnson-Wood K; Schroeter S; Gill D; Jacobsen JS; Pangalos M; Basi G; Games D
    Neurodegener Dis; 2008; 5(2):65-71. PubMed ID: 18182780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
    Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
    J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gantenerumab: a novel human anti-Aβ antibody demonstrates sustained cerebral amyloid-β binding and elicits cell-mediated removal of human amyloid-β.
    Bohrmann B; Baumann K; Benz J; Gerber F; Huber W; Knoflach F; Messer J; Oroszlan K; Rauchenberger R; Richter WF; Rothe C; Urban M; Bardroff M; Winter M; Nordstedt C; Loetscher H
    J Alzheimers Dis; 2012; 28(1):49-69. PubMed ID: 21955818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular alterations in PDAPP mice after anti-Aβ immunotherapy: Implications for amyloid-related imaging abnormalities.
    Zago W; Schroeter S; Guido T; Khan K; Seubert P; Yednock T; Schenk D; Gregg KM; Games D; Bard F; Kinney GG
    Alzheimers Dement; 2013 Oct; 9(5 Suppl):S105-15. PubMed ID: 23583235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid cerebral amyloid binding by Aβ antibodies infused into β-amyloid precursor protein transgenic mice.
    Winkler DT; Abramowski D; Danner S; Zurini M; Paganetti P; Tolnay M; Staufenbiel M
    Biol Psychiatry; 2010 Nov; 68(10):971-4. PubMed ID: 20359696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of age on the duration and extent of amyloid plaque reduction and microglial activation after injection of anti-Abeta antibody into the third ventricle of TgCRND8 mice.
    Chauhan NB; Siegel GJ; Lichtor T
    J Neurosci Res; 2004 Dec; 78(5):732-41. PubMed ID: 15478192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active immunization of mice with an Abeta-Hsp70 vaccine.
    Koller MF; Mohajeri MH; Huber M; Wollmer MA; Roth Z'graggen BV; Sandmeier E; Moritz E; Tracy J; Nitsch RM; Christen P
    Neurodegener Dis; 2004; 1(1):20-8. PubMed ID: 16908970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of A beta plaque clearance following passive A beta immunization.
    Morgan D
    Neurodegener Dis; 2005; 2(5):261-6. PubMed ID: 16909007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramuscular delivery of a single chain antibody gene prevents brain Aβ deposition and cognitive impairment in a mouse model of Alzheimer's disease.
    Wang YJ; Gao CY; Yang M; Liu XH; Sun Y; Pollard A; Dong XY; Wu XB; Zhong JH; Zhou HD; Zhou XF
    Brain Behav Immun; 2010 Nov; 24(8):1281-93. PubMed ID: 20595065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral and central biodistribution of (111)In-labeled anti-beta-amyloid autoantibodies in a transgenic mouse model of Alzheimer's disease.
    Bacher M; Depboylu C; Du Y; Noelker C; Oertel WH; Behr T; Henriksen G; Behe M; Dodel R
    Neurosci Lett; 2009 Jan; 449(3):240-5. PubMed ID: 18786612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
    Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
    Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the efficacy and neuroinflammatory potential of three anti-abeta antibodies.
    Fuller JP; Stavenhagen JB; Christensen S; Kartberg F; Glennie MJ; Teeling JL
    Acta Neuropathol; 2015 Nov; 130(5):699-711. PubMed ID: 26433971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with Abeta-displaying virus-like particles reduces soluble and insoluble cerebral Abeta and lowers plaque burden in APP transgenic mice.
    Bach P; Tschäpe JA; Kopietz F; Braun G; Baade JK; Wiederhold KH; Staufenbiel M; Prinz M; Deller T; Kalinke U; Buchholz CJ; Müller UC
    J Immunol; 2009 Jun; 182(12):7613-24. PubMed ID: 19494285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient near-infrared in vivo imaging of amyoid-β deposits in Alzheimer's disease mouse models.
    Schmidt A; Pahnke J
    J Alzheimers Dis; 2012; 30(3):651-64. PubMed ID: 22460331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice.
    Thal DR; Larionov S; Abramowski D; Wiederhold KH; Van Dooren T; Yamaguchi H; Haass C; Van Leuven F; Staufenbiel M; Capetillo-Zarate E
    Neurobiol Aging; 2007 Aug; 28(8):1221-30. PubMed ID: 16815595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging detection and time course of cerebral microhemorrhages during passive immunotherapy in living amyloid precursor protein transgenic mice.
    Luo F; Rustay NR; Seifert T; Roesner B; Hradil V; Hillen H; Ebert U; Severin JM; Cox BF; Llano DA; Day M; Fox GB
    J Pharmacol Exp Ther; 2010 Dec; 335(3):580-8. PubMed ID: 20823195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.